B BC
Back to Discover Other · English

Blood coagulation

Blood coagulation is a complex physiological process that prevents excessive bleeding when blood vessels are injured. It involves a cascade of biochemical reactions that lead to the formation of a blood clot, primarily composed of platelets and fibrin. Understanding blood coagulation is essential for diagnosing and treating various medical conditions, including hemophilia, vascular diseases, and thrombosis. The study of blood coagulation has evolved significantly over the years, driven by advances in biochemistry and hematology, which have led to the development of both therapeutic and diagnostic tools to manage coagulation disorders effectively.

Creation Time:2025-08-27 14 key nodes English

The Timeline

History Timeline and Biographies

  1. Discovery of Human Blood Groups

    Karl Landsteiner discovered the major human blood groups (A, B, AB, and O), which was crucial for understanding blood transfusion and the subsequent implications for blood coagulation, as blood compatibility is essential for safe medical procedures.
  2. Identification of Coagulation Factors

    The first coagulation factor, Factor I (fibrinogen), was identified, laying the groundwork for understanding the biochemical pathways involved in blood coagulation and their role in hemostasis.
  3. Discovery of Factor VIII

    Factor VIII was identified as a key component in blood coagulation, linking its deficiency to hemophilia A, which underscored the importance of specific factors in the coagulation process.
  4. The Role of Vitamin K in Coagulation

    Researchers discovered that vitamin K is essential for the synthesis of several clotting factors, emphasizing its role in blood coagulation and providing insights into dietary influences on hemostasis.
  5. Introduction of the Prothrombin Time Test

    The prothrombin time (PT) test was introduced as a clinical tool to assess blood coagulation pathways and the effectiveness of anticoagulant therapy, providing critical data for patient management.
  6. Identification of Antithrombin III

    The discovery of antithrombin III, a natural anticoagulant, highlighted the balance between pro-coagulation and anti-coagulation factors affecting blood coagulation and the risk of thrombosis.
  7. The Development of Recombinant Factor VIII

    Recombinant Factor VIII was developed, revolutionizing the treatment of hemophilia A by providing a safe and effective means to manage blood coagulation disorders without the risk of viral transmission from blood products.
  8. Advancements in Anticoagulant Therapy

    New anticoagulant drugs, such as low molecular weight heparins, were introduced, enhancing the management of thromboembolic disorders by targeting key factors in the blood coagulation pathway.
  9. The Discovery of Tissue Factor Pathway Inhibitor

    The discovery of tissue factor pathway inhibitor (TFPI) provided insights into the regulation of blood coagulation and its importance in preventing inappropriate clot formation.
  10. Invention of Point-of-Care Testing for Coagulation

    Point-of-care testing devices for blood coagulation became widely available, enabling rapid assessment of coagulation status in various settings outside of traditional laboratories, enhancing patient care.
  11. Introduction of Novel Oral Anticoagulants (NOACs)

    Novel oral anticoagulants, such as rivaroxaban and apixaban, were approved for clinical use, providing alternatives to traditional anticoagulation therapies by directly targeting specific components of the blood coagulation cascade.
  12. Gene Therapy for Hemophilia

    Advancements in gene therapy aimed at correcting genetic defects causing hemophilia represented a breakthrough in treating blood coagulation disorders, offering potential long-term solutions for patients.
  13. Refinements in Coagulation Factor Concentrates

    Updated formulations of coagulation factor concentrates became available, providing more efficient options for hemophilia management and improving the quality of life for those affected by blood coagulation disorders.
  14. Integration of Artificial Intelligence in Coagulation Management

    The integration of artificial intelligence in diagnosing and managing blood coagulation disorders was introduced, offering personalized treatment plans and enhancing the accuracy of coagulation assessments.

Regeneration always requests fresh AI content and uses 1 query.

Download History Timeline